The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells.

CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiation. J Immunol (2011) 1.36

CD28-independent induction of experimental autoimmune encephalomyelitis. J Clin Invest (2001) 1.10

Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain. Mol Immunol (2007) 1.03

OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol (2009) 1.01

HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation. J Clin Invest (2005) 0.96

A novel adjuvant for vaccine development in the aged. Vaccine (2010) 0.92

The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases. Clin Exp Immunol (2011) 0.92

HIV-1 gp41 and TCRalpha trans-membrane domains share a motif exploited by the HIV virus to modulate T-cell proliferation. PLoS Pathog (2010) 0.92

TNF superfamily: costimulation and clinical applications. Cell Biol Int (2009) 0.83

IL-4 directs the development of Th2-like helper effectors. J Immunol (1990) 7.20

Informal advice- and information-seeking between physicians. J Med Educ (1981) 3.23

Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev (1991) 3.21

Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature (1989) 3.00

Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol (1998) 2.74

Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J Immunol (1988) 2.70

Quantitative analysis of reproducible changes in high-voltage electrophotography. J Altern Complement Med (2001) 2.29

The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg (1999) 2.26

CD4+ T cell subsets. Lymphokine secretion of memory cells and of effector cells that develop from precursors in vitro. J Immunol (1990) 2.08

The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J Immunol (2000) 2.04

Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience (2008) 2.01

Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95

Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol (2001) 1.79

Interaction of lactoferrin, monocytes, and T lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro. J Clin Invest (1981) 1.79

Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat Med (1996) 1.78

Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65

Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64

Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63

Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health (1988) 1.53

Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol (1999) 1.50

Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol (2001) 1.48

Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci U S A (1991) 1.47

Design, engineering and production of functional single-chain T cell receptor ligands. Protein Eng (1999) 1.46

Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different. J Exp Med (1989) 1.44

Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res (1984) 1.40

Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells. J Immunol (2001) 1.35

T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis. Science (1991) 1.30

Molecular cloning of a functional bovine interleukin 2 cDNA. Proc Natl Acad Sci U S A (1986) 1.29

Inappropriate hospitalization of nursing facility residents: a symptom of a sick system of care for frail older people. J Am Geriatr Soc (2000) 1.29

Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat Med (1996) 1.25

Breast cancer screening: racial/ethnic differences in behaviors and beliefs. J Cancer Educ (1995) 1.23

Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4. J Immunol (2001) 1.23

Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J Neuroimmunol (1992) 1.20

Recombinant human beta-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J Neuroimmunol (1990) 1.20

Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. II. Biased T cell receptor V beta expression predominates in spinal cord infiltrating T cells. J Immunol (1992) 1.19

Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor. J Immunol (2001) 1.19

Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules. J Neurosci Res (1989) 1.16

Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation (1995) 1.16

Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis. J Immunol (1998) 1.14

17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res (2001) 1.14

Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction. Ann Thorac Surg (2001) 1.14

De novo solid malignancies after cardiac transplantation. Ann Thorac Surg (1995) 1.13

Specificity of T lymphocyte lines for peptides of myelin basic protein. J Immunol (1985) 1.13

Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol (1998) 1.12

Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J Immunol (1991) 1.11

Male SJL mice do not relapse after induction of EAE with PLP 139-151. J Neurosci Res (1996) 1.11

Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J Clin Invest (2000) 1.10

Outcomes in seriously ill neonates with coarctation of the aorta. A multiinstitutional study. J Thorac Cardiovasc Surg (1994) 1.09

Association of melanoma tumor antigen activity with beta2-microglobulin. Cancer Res (1979) 1.06

Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen-presenting cells influences immunodominant epitope of basic protein. J Immunol (1986) 1.04

The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant (1997) 1.03

Induction of anti-mammary cancer immunity by engaging the OX-40 receptor in vivo. Breast Cancer Res Treat (2001) 1.02

Regulation of encephalitogenic T cells with recombinant TCR ligands. J Immunol (2000) 1.01

Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein. J Neurosci Res (1991) 1.01

Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1. J Virol (1989) 0.99

A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis. J Immunol (1985) 0.99

The evaluation of an integrated cardiovascular health education and government course in a secondary school. Health Educ (1990) 0.98

Induction of experimental autoimmune encephalomyelitis in severe combined immunodeficient mice reconstituted with allogeneic or xenogeneic hematopoietic cells. J Immunol (1993) 0.98

Target organ-specific up-regulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J Immunol (1994) 0.98

Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice. J Immunol (1991) 0.98

Pitfalls in interpreting prostate specific antigen velocity. J Urol (1996) 0.97

Breast cancer screening behaviors and intentions among asymptomatic women 50 years of age and older. Am J Prev Med (1996) 0.97

Human transfer factor: effects on lymphocyte transformation. J Immunol (1976) 0.96

Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet (1999) 0.96

Transforming growth factor-beta enhances the in vivo effector function and memory phenotype of antigen-specific T helper cells in experimental autoimmune encephalomyelitis. J Immunol (1992) 0.96

Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant (1996) 0.95

Human transfer factor activity in the guinea pig: absence of antigen specificity. Clin Immunol Immunopathol (1977) 0.95

Integrating cardiovascular health education with an English curriculum in a secondary school. J Sch Health (1984) 0.95

Inactivation of S-adenosylhomocysteine hydrolase by 5'-deoxy-5'-methylthioadenosine. Biochem Biophys Res Commun (1981) 0.95

Letter: Inhibition of lymphocyte response to stimulants induced by unsaturated fatty acids and prostaglandins. Lancet (1974) 0.95

Characterization of the immune response to a secondary encephalitogenic epitope of basic protein in Lewis rats. I. T cell receptor peptide regulation of T cell clones expressing cross-reactive V beta genes. J Immunol (1992) 0.94

Early detection of skin cancer: racial/ethnic differences in behaviors and attitudes. J Cancer Educ (1994) 0.94

Progesterone treatment reduces disease severity and increases IL-10 in experimental autoimmune encephalomyelitis. J Neuroimmunol (2010) 0.93

Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg (1996) 0.93

Gangliosides induce selective modulation of CD4 from helper T lymphocytes. J Immunol (1987) 0.93